204 related articles for article (PubMed ID: 7048863)
1. Antifibrinolytic treatment in subarachnoid haemorrhage: present state.
Fodstad H
Acta Neurochir (Wien); 1982; 63(1-4):233-44. PubMed ID: 7048863
[TBL] [Abstract][Full Text] [Related]
2. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.
Baharoglu MI; Germans MR; Rinkel GJ; Algra A; Vermeulen M; van Gijn J; Roos YB
Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD001245. PubMed ID: 23990381
[TBL] [Abstract][Full Text] [Related]
3. Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).
Fodstad H; Nilsson IM
Acta Neurochir (Wien); 1981; 56(1-2):25-38. PubMed ID: 7195642
[TBL] [Abstract][Full Text] [Related]
4. Antifibrinolytics in aneurysmal subarachnoid haemorrhage. A retrospective comparison of two different forms of antifibrinolytic therapy.
Spallone A
Acta Neurochir (Wien); 1982; 63(1-4):245-50. PubMed ID: 6179402
[TBL] [Abstract][Full Text] [Related]
5. Tranexamic acid in the preoperative management of ruptured intracranial aneurysms.
Fodstad H; Liliequist B; Schannong M; Thulin CA
Surg Neurol; 1978 Jul; 10(1):9-15. PubMed ID: 356311
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic activity of cerebral tissue after experimental subarachnoid haemorrhage: inhibitory effect of tranexamic acid (AMCA).
Fodstad H; Kok P; Algers G
Acta Neurol Scand; 1981 Jul; 64(1):29-46. PubMed ID: 7198859
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid.
Tsementzis SA; Honan WP; Nightingale S; Hitchcock ER; Meyer CH
Acta Neurochir (Wien); 1990; 103(3-4):116-21. PubMed ID: 2205078
[TBL] [Abstract][Full Text] [Related]
8. The role of antifibrinolytic therapy in the preoperative management of recently ruptured intracranial aneurysms.
Guidetti B; Spallone A
Surg Neurol; 1981 Apr; 15(4):239-48. PubMed ID: 6166061
[TBL] [Abstract][Full Text] [Related]
9. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study.
Hillman J; Fridriksson S; Nilsson O; Yu Z; Saveland H; Jakobsson KE
J Neurosurg; 2002 Oct; 97(4):771-8. PubMed ID: 12405362
[TBL] [Abstract][Full Text] [Related]
10. [Experimental studies on the diffusion of antifibrinolytic agents in fibrin thrombi. A contribution to intrathecal antifibrinolytic therapy in subarachnoid hemorrhages].
Hindersin P; Senf L; Richter M; Endler S
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):313-8. PubMed ID: 6179834
[TBL] [Abstract][Full Text] [Related]
11. Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial.
Fodstad H; Forssell A; Liliequist B; Schannong M
Neurosurgery; 1981 Feb; 8(2):158-65. PubMed ID: 7010203
[TBL] [Abstract][Full Text] [Related]
12. Rebleeding, ischaemia and hydrocephalus following anti-fibrinolytic treatment for ruptured cerebral aneurysms: a retrospective clinical study.
Pinna G; Pasqualin A; Vivenza C; Da Pian R
Acta Neurochir (Wien); 1988; 93(3-4):77-87. PubMed ID: 3177035
[TBL] [Abstract][Full Text] [Related]
13. Antifibrinolytic therapy in the treatment of aneurysmal subarachnoid hemorrhage.
Kassell NF; Haley EC; Torner JC
Clin Neurosurg; 1986; 33():137-45. PubMed ID: 3491721
[TBL] [Abstract][Full Text] [Related]
14. Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm.
Ramirez-Lassepas M
Neurology; 1981 Mar; 31(3):316-22. PubMed ID: 7010208
[TBL] [Abstract][Full Text] [Related]
15. Clinical application of inhibitors of fibrinolysis.
Verstraete M
Drugs; 1985 Mar; 29(3):236-61. PubMed ID: 2580684
[TBL] [Abstract][Full Text] [Related]
16. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.
Roos YB; Rinkel GJ; Vermeulen M; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (2):CD001245. PubMed ID: 12804399
[TBL] [Abstract][Full Text] [Related]
17. Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy.
Leipzig TJ; Redelman K; Horner TG
J Neurosurg; 1997 Feb; 86(2):220-5. PubMed ID: 9010423
[TBL] [Abstract][Full Text] [Related]
18. Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage.
Fodstad H; Pilbrant A; Schannong M; Strömberg S
Acta Neurochir (Wien); 1981; 58(1-2):1-13. PubMed ID: 7282453
[TBL] [Abstract][Full Text] [Related]
19. [Current status of intrathecal antifibrinolytic therapy with p-aminomethylbenzoic acid (PAMBA) in subarachnoid hemorrhages].
Hindersin P; Endler S; Heidrich R; Lehmann W; Dietrich J
Psychiatr Neurol Med Psychol (Leipz); 1985 Dec; 37(12):686-9. PubMed ID: 3879362
[TBL] [Abstract][Full Text] [Related]
20. Are antifibrinolytic agents effective in the treatment of aneurysmal subarachnoid hemorrhage?
Eastin TR; Snipes CD; Seupaul RA
Ann Emerg Med; 2014 Dec; 64(6):658-9. PubMed ID: 24954579
[No Abstract] [Full Text] [Related]
[Next] [New Search]
